创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

环状RNA技术及其在生物医药领域的研发进展

Circular RNA Technology and Its Research and Development Progress in Biomedical Field

  • 摘要: 环状核糖核酸(circRNA)是一种单链闭环RNA分子,因其高稳定性、低免疫原性及广阔应用前景而备受关注。简介天然circRNA的生物学功能,探讨circRNA在药物研发中的多样化应用,特别是在开发核酸适配体、海绵circRNA、向导circRNA、circRNA疫苗和circRNA嵌合抗原受体T细胞免疫疗法(chimeric antigen receptor T-cell immunotherapy,CAR-T)等方面的最新研究动态。同时,详细介绍circRNA的体外合成技术(包括化学合成和酶促合成),并深入分析circRNA药物开发过程中所面临挑战。展望circRNA技术的未来发展前景,强调其在疫苗开发和治疗性药物领域的巨大潜力。

     

    Abstract: Circular RNAs (circRNAs), single-stranded covalently closed RNA molecules characterized by unique topological structures, have emerged as pivotal tools in biomedical research due to their exceptional biostability, low immunogenicity, and therapeutic versatility. This review briefly introduces the biological functions of endogenous circRNA and discusses their expanding applications in drug development, with a focus on the latest trends in the development of circRNA aptamers, circRNA sponge, guide circRNA, circRNA-based vaccines and circRNA-based CAR-T immunotherapies. Besides, it comprehensively analyzes the in vitro synthesizing methodologies, including chemical and enzymatic strategies, and analyzes in depth the challenges in circRNA drug development, The review concludes by exploring future directions for circRNA technology and its transformative potential in advancing the development of vaccines and therapeutics.

     

/

返回文章
返回